Cargando…
Circulating FGF21 Concentration, Fasting Plasma Glucose, and the Risk of Type 2 Diabetes: Results From the PREVEND Study
OBJECTIVE: Fibroblast growth factor 21 (FGF21) is a peptide hormone synthesized by several organs and regulates, among others, energy homeostasis. In obesity, insulin resistance and type 2 diabetes (T2D), higher circulating FGF21 concentrations have been found. Temporal analyses in murine studies de...
Autores principales: | Post, Adrian, Dam, Wendy A, Sokooti, Sara, Groothof, Dion, Gloerich, Jolein, van Gool, Alain J, Kremer, Daan, Gansevoort, Ron T, van den Born, Jacob, Kema, Ido P, Franssen, Casper F M, Dullaart, Robin P F, Bakker, Stephan J L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188302/ https://www.ncbi.nlm.nih.gov/pubmed/36533509 http://dx.doi.org/10.1210/clinem/dgac729 |
Ejemplares similares
-
Plasma creatine and incident type 2 diabetes in a general population‐based cohort: The PREVEND study
por: Post, Adrian, et al.
Publicado: (2021) -
Plasma creatine concentration is associated with incident hypertension in a cohort enriched for the presence of high urinary albumin concentration: the Prevention of Renal and Vascular Endstage Disease study
por: Post, Adrian, et al.
Publicado: (2022) -
Fasting Proinsulin Independently Predicts Incident Type 2 Diabetes in the General Population
por: Sokooti, Sara, et al.
Publicado: (2022) -
Dietary lithium intake, graft failure and mortality in kidney transplant recipients
por: Post, Adrian, et al.
Publicado: (2022) -
Lipoprotein particle sizes and incident type 2 diabetes: the PREVEND cohort study
por: Sokooti, Sara, et al.
Publicado: (2021)